WallStSmart

Tenet Healthcare Corporation (THC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Tenet Healthcare Corporation stock (THC) is currently trading at $200.35. Tenet Healthcare Corporation PE ratio is 12.93. Tenet Healthcare Corporation PS ratio (Price-to-Sales) is 0.83. Analyst consensus price target for THC is $261.38. WallStSmart rates THC as Moderate Buy.

  • THC PE ratio analysis and historical PE chart
  • THC PS ratio (Price-to-Sales) history and trend
  • THC intrinsic value — DCF, Graham Number, EPV models
  • THC stock price prediction 2025 2026 2027 2028 2029 2030
  • THC fair value vs current price
  • THC insider transactions and insider buying
  • Is THC undervalued or overvalued?
  • Tenet Healthcare Corporation financial analysis — revenue, earnings, cash flow
  • THC Piotroski F-Score and Altman Z-Score
  • THC analyst price target and Smart Rating
THC

Tenet Healthcare Corporation

NYSEHEALTHCARE
$200.35
$4.76 (-2.32%)
52W$109.82
$247.21
Target$261.38+30.5%

📊 No data available

Try selecting a different time range

IV

THC Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Tenet Healthcare Corporation (THC)

Margin of Safety
+68.8%
Strong Buy Zone
THC Fair Value
$724.93
Graham Formula
Current Price
$200.35
$524.58 below fair value
Undervalued
Fair: $724.93
Overvalued
Price $200.35
Graham IV $724.93
Analyst $261.38

THC trades at a significant discount to its Graham intrinsic value of $724.93, offering a 69% margin of safety — a level value investors typically seek before buying.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Tenet Healthcare Corporation (THC) · 10 metrics scored

Smart Score

66
out of 100
Grade: B-
Strong Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in market cap, return on equity, price/sales. Concerns around peg ratio. Overall metrics suggest strong investment potential with favorable risk/reward.

Tenet Healthcare Corporation (THC) Key Strengths (5)

Avg Score: 9.4/10
Return on EquityProfitability
27.00%10/10

Every $100 of shareholder equity generates $27 in profit

Price/SalesValuation
0.8310/10

Paying less than $1 for every $1 of annual revenue

Institutional Own.Quality
99.17%10/10

99.17% of shares held by major funds and institutions

Market CapQuality
$17.61B9/10

Large-cap company with substantial market presence

EPS GrowthGrowth
27.60%8/10

Strong earnings growth at 27.60% per year

Supporting Valuation Data

P/E Ratio
12.93
Undervalued
Forward P/E
11.76
Attractive
Trailing P/E
12.93
Undervalued
Price/Sales (TTM)
0.826
Undervalued
EV/Revenue
1.3
Undervalued
THC Target Price
$261.38
23% Upside

Tenet Healthcare Corporation (THC) Areas to Watch (5)

Avg Score: 4.0/10
PEG RatioValuation
4.712/10

Very expensive relative to growth, significant premium

Price/BookValuation
4.134/10

Premium pricing at 4.1x book value

Revenue GrowthGrowth
8.90%4/10

Modest revenue growth at 8.90%

Profit MarginProfitability
6.60%4/10

Thin profit margins with limited profitability

Operating MarginProfitability
17.50%6/10

Decent operational efficiency, solid but not exceptional

Tenet Healthcare Corporation (THC) Detailed Analysis Report

Overall Assessment

This company scores 66/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 5 register as strengths (avg 9.4/10) while 5 fall into concern territory (avg 4.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Return on Equity, Price/Sales, Institutional Own.. Valuation metrics including Price/Sales (0.83) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 27.00%. Growth metrics are encouraging with EPS Growth at 27.60%.

The Bear Case

The primary concerns are PEG Ratio, Price/Book, Revenue Growth. Some valuation metrics including PEG Ratio (4.71), Price/Book (4.13) suggest expensive pricing. Growth concerns include Revenue Growth at 8.90%, which may limit upside. Profitability pressure is visible in Operating Margin at 17.50%, Profit Margin at 6.60%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether PEG Ratio improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 27.00% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 8.90% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (Return on Equity, Price/Sales) and negatives (PEG Ratio, Price/Book). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

Compare THC with Competitors

Top MEDICAL CARE FACILITIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Tenet Healthcare Corporation (THC) · HEALTHCAREMEDICAL CARE FACILITIES

The Big Picture

Tenet Healthcare Corporation operates as a stable business with moderate growth and solid fundamentals. Revenue reached 21.3B with 9% growth year-over-year. Profit margins are thin at 6.6%, typical for companies in this phase that are reinvesting heavily in growth.

Key Findings

Excellent Capital Efficiency

ROE of 2700.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.

Cash Flow Positive

Generating 367M in free cash flow and 731M in operating cash flow. Earnings are translating into actual cash generation.

What to Watch Next

Margin expansion: can Tenet Healthcare Corporation push profit margins above 15% as the business scales?

Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Tenet Healthcare Corporation.

Bottom Line

Tenet Healthcare Corporation offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Tenet Healthcare Corporation(THC)

Exchange

NYSE

Sector

HEALTHCARE

Industry

MEDICAL CARE FACILITIES

Country

USA

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.